Single‐dose, placebo‐controlled, randomized study of AMG 785, a sclerostin monoclonal antibody
By D. Padhi, G. Jang, B. Stouch, Liang Fang, Edward Posvar. Journal of Bone and Mineral Research, 2011
800 citations recorded by the source corpus.
Subfields: Molecular Biology, Oncology, Orthopedics and Sports Medicine
View Paper: https://www.semanticscholar.org/paper/ab13576638ddb5c1c76963c8dae443813a7a5232
How researchers see this paper
The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.
In Molecular Biology
In Oncology
In Orthopedics and Sports Medicine
Citations in the corpus
- Cellular mechanisms of bone remodeling (2010, background): “Preliminary studies with a humanized monoclonal antibody against sclerostin have shown bone anabolism in animals as well as humans [25].”
- The Amazing Osteocyte (2010, background): “Antibody to sclerostin is being considered as a new drug against postmenopausal osteoporosis((55,56)) because of its specificity and its anabolic effect on bone formation.”